Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 272

1.

Selectin haplotypes and the risk of venous thrombosis: influence of linkage disequilibrium with the factor V Leiden mutation.

Uitte de Willige S, De Visser MC, Vos HL, Houwing-Duistermaat JJ, Rosendaal FR, Bertina RM.

J Thromb Haemost. 2008 Mar;6(3):478-85. doi: 10.1111/j.1538-7836.2007.02879.x. Epub 2007 Dec 19.

2.

The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.

de Visser MC, Guasch JF, Kamphuisen PW, Vos HL, Rosendaal FR, Bertina RM.

Thromb Haemost. 2000 Apr;83(4):577-82.

PMID:
10780320
3.

AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.

Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J.

Haematologica. 2008 May;93(5):729-34. doi: 10.3324/haematol.12271. Epub 2008 Apr 2.

4.
5.

Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis.

Uitte de Willige S, Van Marion V, Rosendaal FR, Vos HL, de Visser MC, Bertina RM.

J Thromb Haemost. 2004 Aug;2(8):1305-10.

6.

Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.

González-Porras JR, García-Sanz R, Alberca I, López ML, Balanzategui A, Gutierrez O, Lozano F, San Miguel J.

Blood Coagul Fibrinolysis. 2006 Jan;17(1):23-8.

PMID:
16607075
7.

Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis.

Meltzer ME, Lisman T, Doggen CJ, de Groot PG, Rosendaal FR.

PLoS Med. 2008 May 6;5(5):e97. doi: 10.1371/journal.pmed.0050097.

8.

Mechanisms of the factor V Leiden paradox.

van Stralen KJ, Doggen CJ, Bezemer ID, Pomp ER, Lisman T, Rosendaal FR.

Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1872-7. doi: 10.1161/ATVBAHA.108.169524. Epub 2008 Jul 10.

PMID:
18617648
9.
10.

Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.

Tirado I, Mateo J, Soria JM, Oliver A, Borrell M, Coll I, Vallvé C, Souto JC, Martínez-Sánchez E, Fontcuberta J.

Haematologica. 2001 Nov;86(11):1200-8.

11.

Polymorphisms in the protein C gene as risk factor for venous thrombosis.

Pomp ER, Doggen CJ, Vos HL, Reitsma PH, Rosendaal FR.

Thromb Haemost. 2009 Jan;101(1):62-7.

PMID:
19132190
12.

Deep venous thrombosis and thrombophilic mutations in western Iran: association with factor V Leiden.

Rahimi Z, Mozafari H, Shahriari-Ahmadi A, Alimogaddam K, Ghavamzadeh A, Aznab M, Mansouri K, Rezaei M, Parsian A.

Blood Coagul Fibrinolysis. 2010 Jul;21(5):385-8. doi: 10.1097/MBC.0b013e328330e69a.

PMID:
20479641
13.

P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism.

Ay C, Jungbauer LV, Kaider A, Koder S, Panzer S, Pabinger I, Mannhalter C.

Thromb Haemost. 2008 May;99(5):899-904. doi: 10.1160/TH07-11-0672.

PMID:
18449419
14.

Ala147Thr and C+1542G polymorphisms in the TAFI gene are not asssociated with a higher risk of venous thrombosis in FV Leiden carriers.

Morange PE, Aillaud MF, Nicaud V, Henry M, Juhan-Vague I.

Thromb Haemost. 2001 Dec;86(6):1583-4. No abstract available.

PMID:
11776333
15.

A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.

Bouaziz-Borgi L, Nguyen P, Hezard N, Musharrafieh U, Almawi WY, Mahjoub T.

Exp Mol Pathol. 2007 Dec;83(3):480-3. Epub 2007 May 6.

PMID:
17555744
16.

[Factor V Leiden and prothrombin G20210A among Chilean patients with venous and arterial thrombosis].

Palomo I, Pereira J, Alarcón M, Pinochet C, Vélez MT, Hidalgo P, Skagerberg K, Poblete F.

Rev Med Chil. 2005 Dec;133(12):1425-33. Epub 2006 Jan 27. Spanish.

17.

Venous thrombotic risk in family members of unselected individuals with factor V Leiden.

Lensen RP, Bertina RM, de Ronde H, Vandenbroucke JP, Rosendaal FR.

Thromb Haemost. 2000 Jun;83(6):817-21.

PMID:
10896231
18.

Candidate gene approach in association studies: would the factor V Leiden mutation have been found by this approach?

van Hylckama Vlieg A, Sandkuijl LA, Rosendaal FR, Bertina RM, Vos HL.

Eur J Hum Genet. 2004 Jun;12(6):478-82.

19.

Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.

Abramson N, Costantino JP, Garber JE, Berliner N, Wickerham DL, Wolmark N.

J Natl Cancer Inst. 2006 Jul 5;98(13):904-10.

PMID:
16818854
20.

Prothrombin A19911G polymorphism and the risk of venous thromboembolism.

Martinelli I, Battaglioli T, Tosetto A, Legnani C, Sottile L, Ghiotto R, Mannucci PM.

J Thromb Haemost. 2006 Dec;4(12):2582-6. Epub 2006 Sep 15.

Supplemental Content

Support Center